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Specific elimination of Hepatitis B virus infected hepatocytes by modified 
human T cells which express chimeric T-cell receptors and establish a 
cytotoxic T-cell response  
 
For a proportion of patients, HBV infection results in chronic disease with severe consequences 
like liver cirrhosis or hepatocellular carcinoma. This results from a weak and oligoclonal T-cell 
response targeting only limited HBV epitopes. A major goal in the therapy of chronic HBV 
infection is the elimination of the episomal replication template, the so called covalently closed 
circular DNA (cccDNA). The therapeutic approaches are inhibitors of viral replication (interferon 
alpha) or inhibitors of viral reverse transcription (Lamivudin). By these means replication is 
controlled partially but cccDNA persists, generating a relapse of infection after therapy has 
ceased. A possible immunotherapeutical approach for a successful treatment could be achieved 
by receptormodified T-cells inducing an artificial T-cell response. Therefore, T-cells were 
equipped with recombinant T-cell receptors, using single chain antibody fragments (scFv) for 
antigen recognition and hence being independent of peptide antigen presentation via MHC-
molecules. The chimeric T-cell receptors, generated in this work, are directed against two HBV 
surface proteins, which are present on the surface of infected cells, as a result of virus production 
and secretion. Modified T-cells were activated upon antigen recognition resulting in the 
generation of a T-cell receptor signal and a costimulatory signal provided by a modular signalling 
domain. HBV-infected primary human hepatocytes were specifically eliminated and the episomal 
replication template was removed. Furtheron activation led to the secretion of proinflammatory 
interferon gamma and of interleukin-2. This generated a proliferative signal inducing an antigen 
specific expansion of receptor modified T-cells. Apoptosis of target cells was mediated through 
degranulation of perforin and granzyme containing vesicles and activation of NFkappaB and 
proapoptotic effector caspases 3 and 7 was observed. These results demonstrate that a 
genetherapeutic modification of T-cells results in specific elimination of HBV infected 
hepatocytes. Since the therapeutic goal, the elimination of cccDNA was achieved, this system 
could be a promising alternative to the actual standard therapeutics against HBV.  
